Arbutus Biopharma Corp·4

Dec 13, 3:11 PM ET

VandenEnden Koert 4

4 · Arbutus Biopharma Corp · Filed Dec 13, 2018

Insider Transaction Report

Form 4
Period: 2018-12-11
VandenEnden Koert
Chief Accounting Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-12-11+7,5007,500 total
    Exercise: $4.44Exp: 2028-12-11Common Shares (7,500 underlying)
Footnotes (1)
  • [F1]The option will vest on termination of employment.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT